缬沙坦与硝苯地平缓释片治疗原发性高血压临床疗效分析

Analysis of Valsartan and Extended Release Nifedipine Tablets in Treatment of Primary Hypertension Clinical Curative Effect

目的：分析并研究缬沙坦与硝苯地平缓释片治疗原发性高血压的临床效果。方法选择我院在2012年9月～2014年9月收治的142例原发性高血压患者作为研究对象，将其随机分为观察组和对照组，每组71例。对照组患者在常规治疗基础上配合硝苯地平缓释片进行治疗，观察组患者在常规治疗基础上采用缬沙坦＋硝苯地平缓释片进行治疗。观察并比较两组患者的治疗效果。结果观察组患者的治疗效果明显比对照组显著，有效治愈患者68例，治疗有效率为95.77%，对照组治愈患者48例，治疗有效为67.61%，两组比较差异显著，P＜0.05，具有统计学意义；且观察组患者的并发症更少，复发率更低，患者的满意度更高，与对照组相比，P＜0.05，具有统计学意义。结论关于原发性高血压的临床治疗，在常规治疗的基础上配合缬沙坦＋硝苯地平缓释片能够取得更为显著的效果，可以提高患者的治愈率，减少患者的复发。

Objective To analyze the clinical effects and the effects of valsartan and nifedipine sustained-release tablets in the treatment of primary hypertension. Methods 142 patients with primary hypertension patients as the research object, then they were randomly divided into observation group and control group. Patients in the control group on the basis of conventional treatment combined with nifedipine sustained release tablets for treatment, the observation group were treated by valsartan＋nifedipine sustained release on the basis of conventional therapy were treated. The treatment effect of the two groups were observed and compared. Results The observation group patients with obvious treatment effect signiifcantly compared to the control group and the observation group patients, fewer complications, the recurrence rate is lower and higher satisfaction of patients. Conclusion The treatment of essential hypertension with valsartan and nifedipine sustained-release tablets on the basis of conventional treatment can get a more pronounced effect, can improve the cure rate of patients, reduce the recurrence of patients.